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Introduction 
In the current SARS-CoV-2 (COVID-19) pandemic, 
testing has become a cornerstone for public 
health advice, policies and political agenda. The 
unprecedented and exponential growth of non-peer-
reviewed publications, systematic reviews lacking 
rigorous thoroughness and the repetitive inclusion 
of case reports is problematic (Bauchner, 2020). 
We critically appraised the limitations and manner 
of diagnostic testing in obstetric medicine (Bahadur 
et al., 2020). While the genetic sequence for SARS-
CoV-2 became available (Wang et al., 2020), it was 
only after mid-April 2020 that profound concerns 
were aired about the very high false-negative rates for 
antibodies. This false-negative rate for antibodies has 
come down from almost 1 in 2 to 1 in 3 tests, possibly 
because the reverse transcription polymerase chain 
reaction (RT-PCR) tests were based on the previous 
SARS family virus (Bahadur et al., 2020).
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Abstract
Research question: Is there vertical transmission (from mother to baby antenatally or intrapartum) after SARS-
CoV-2 (COVID-19) infected pregnancy?
Study design: A systematic search related to SARS-CoV-2 (COVID-19), pregnancy, neonatal complications, viral 
and vertical transmission. The duration was from December 2019 to May 2020.
Results: A total of 84 studies with 862 COVID positive women were included. Two studies had ongoing pregnancies 
while 82 studies included 705 babies, 1 miscarriage and 1 medical termination of pregnancy (MTOP). Most 
publications (50/84, 59.5%), reported small numbers (<5) of positive babies. From 75 studies, 18 babies were 
COVID-19 positive. The first reverse transcription polymerase chain reaction (RT-PCR) diagnostic test was done 
in 449 babies and 2 losses, 2nd RT-PCR was done in 82 babies, IgM tests were done in 28 babies, and IgG tests 
were done in 28 babies. On the first RT-PCR, 47 studies reported time of testing while 28 studies did not. Positive 
results in the first RT-PCR were seen in 14 babies. Earliest tested at birth and the average time of the result was 
22 hours. Three babies with negative first RT-PCR became positive on the second RT-PCR at day 6, day 7 and at 
24 hours which continued to be positive at 1 week. 
Four studies with a total of 4 placental swabs were positive demonstrating SARS-CoV-2 localised in the placenta. 
In 2 studies, 10 tests for amniotic fluid were positive for SARS-CoV-2. These 2 babies were found to be positive 
on RT-PCR on serial testing. 
Conclusion: Diagnostic testing combined with incubation period and placental pathology indicate a strong 
likelihood that intrapartum vertical transmission of SARS-CoV-2 (COVID-19) from mother to baby is possible.
Key words: COVID-19, SARS-CoV-2, pregnancy, risks, vertical transmission.
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The second major limitation is the fact that most 
researchers had not taken account of the incubation 
period, which for SARS-CoV-2 is 5-6 days (Li Q 
et al., 2020) and most publications have relied on a 
single test rather than serial checks, thereby producing 
scientifically unreliable conclusions. There is also the 
possibility that latent infections exist even before the 
onset of symptoms (Anderson et al., 2020) and the 
earliest trigger for transmission occurs before the 
onset of symptoms which could be one to two days if 
with viraemia (Zou et al., 2020). The safety margins 
to assess the likelihood of infection before the onset of 
infection should be revised towards 7-8 days, which 
is different from the World Health Organisation 
(WHO) RT-PCR testing recommendation for the 
asymptomatic or mildly symptomatic (WHO, 2020). 
Asymptomatic carriers acquiring and transmitting 
SARS-CoV-2 remains an underexplored area (Bai et 
al., 2020) against those cases with confirmed SARS-
CoV-2 clinical symptoms (Huang et al., 2020).
Serological testing is a measure of a by-gone event 
(WHO, 2020) with probable clues on the long-term 
immunity or immunological memory and route to 
immunisation (Dijkstra et al., 2020). IgM provides the 
initial defence to viral infections, before generating 
the adaptive IgG response. From 173 SARS-CoV-2 
infected patients and 535 plasma samples, the 
median seroconversion time for total antibody (Ab), 
IgM and then IgG was day 11, day 12 and day 14, 
respectively. The antibodies were present in <40% 
among patients within 1-week of onset, and rapidly 
increased to 100 % (Ab), 94.3% (IgM) and 79.8% 
(IgG) 15 days after onset (Jacofsky et al., 2020; Li 
Z et al., 2020). Furthermore, cross-reactivity against 
multiple coronavirus strains with similar antigen sites 
can become problematic (Jacofsky et al., 2020; Xiao 
et al., 2020).
This retrospective observational study on RT-PCR 
analyses on babies born to SARS-CoV-2 positive 
mothers sets out to analyse how SARS-CoV-2 
diagnostic analyses and placental analyses were 
performed, their scientific limitations in interpreting 
data and whether intrapartum vertical transmission 
from mother to baby was possible.
Methods
Study design, size, duration
A systematic review searching terms related to 
SARS-CoV-2, COVID-19, pregnancy, neonatal 
complications, viral and vertical transmission was 
conducted. No language restriction was placed on 
published articles. The duration was from 1st December 
2019 to 15th May 2020 for extracting the literature and 
screening the articles of potential interest.
Participants/materials, setting, methods
A systematic review following the PRISMA format 
was performed in PUBMED, EMBASE, CENTRAL, 
WEB of SCIENCE, Web of Knowledge, the WHO, 
RCOG, ESHRE, ASRM, NEJM, BMJ, Lancet, 
Welcome and Cochrane Central Register of Studies, 
UKOSS, Office of National Statistics (ONS-UK), 
Department of Health (UK), Google Scholar and 
any references of relevant articles. Data relevant 
to SARS-CoV-2 diagnostic interpretation was also 
collected. Case reports or case series of pregnant 
women with confirmed COVID-19, where neonatal 
outcomes were reported were assembled on an 
Excel spreadsheet.
Results
A total of 84 studies with 862 COVID-19 positives 
were included. Two studies had ongoing pregnancies 
while the remaining 82 studies included 705 babies, 
one miscarriage and one medical termination of 
pregnancy (MTOP). 
Of the 84 studies, 1st RT-PCR was undertaken 
in 449 babies and two losses in 75 studies. Seven 
studies did not report testing, while two had ongoing 
pregnancies. Forty-one studies had only one RT-
PCR testing done. 34 studies had a 2nd RT-PCR 
done. Overall excluding two losses, there were 
431 negative, 14 positive and four unclear results 
(total=449) in the 1st RT-PCR. 356/431(82.5%) 
babies had only one negative RT-PCR (no serial 
testing). The time at which 1st RT-PCR was done 
was recorded in 47 studies (165/449 babies) but 
not in 28 studies (284/449 babies). Considering 
the 47 studies with 165 babies, the mean times of 
negative and positive results were 28 hours (day 1 
after birth, day 1) and 22 hours (day of birth, day 
0) respectively. 2nd RT-PCR was reported in 34 
studies and 82 babies. 74 were negative and eight 
were positive. The mean time of negative result was 
92 hours / day 4 (Figure 1). 
Positive results in 1st RT-PCR were documented 
in 14 babies. The earliest were tested at birth and 
the average time of the result was 22 hours/ day 0. 
Three babies with negative 1st RT-PCR became 
positive in 2nd RT-PCR at D6, D7 and at 24 hours 
which continued to test positive at 1 week. One 
baby with an equivocal result with 1st RT-PCR 
became positive in subsequent testing on day 3 
(Figure 1, Table 1).
Antibody testing (IgM/IgG) was done in 28 
babies from six studies. Twenty-one babies had 
negative results, while 7 (25%) were positive (3 
had positive IgM and all 7 had positive IgG). All 
three babies with positive IgM had negative RT-
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Figure 1:  1st and 2nd RT PCR testing in babies born to COVID 19 
positive mothers.
PCR. IgG could be acquired by transfer from mum 
through the placenta. All except one baby with 
positive IgG had a positive 1st RT-PCR. When this 
same swab was repeated after 37 hours, RT-PCR 
was negative. In the two studies where babies were 
positive for IgM, no information was available on 
placental swabs, cord blood or amniotic fl uid.
One baby with negative antibody testing had 
positive 1st RT-PCR at 16 hrs after birth and the 
mother became antibody positive on postpartum 
day 4. 
In order to confirm vertical transmission, 
amniotic fl uid, and placenta and cord blood were 
assessed for evidence of infection with SARS-CoV-2 
by RT-PCR results. In 15 studies (46 women) had 
sent placental swabs. Four studies with a total of four 
placental swabs were positive. Positive placental 
swabs on histology demonstrated SARS-CoV-2 
localised predominantly to the syncytiotrophoblast 
cells of the placenta.
In 17 studies, amniotic fl uid from 67 women 
was tested for COVID-19. In two studies, 10 tests 
were positive. In these, two babies were found to be 
positive on RT-PCR on serial testing. 
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Cord blood samples were tested in 77 cases (in 
15 studies) and all except one was negative. This 
particular study included one woman who had a 
MTOP for maternal compromise with severe pre-
eclampsia and COVID-19 infection with possible 
placental abruption. Fetal heart and lung tissues 
tested negative for SARS-CoV-2, whilst placenta 
and cord blood were found to be positive. 
Out of the 705 babies and 2 non-viable fetuses, 
18 babies were found to be positive on at least one 
RT-PCR testing. Timing and serial testing were 
done in 82 babies (>= 2 tests).
Discussion
Pregnant women are considered to be a high-risk 
group for SARS-CoV-2 infection, with potentially 
adverse maternal and perinatal outcomes, with an 
Study No. of babies 
tested/total 
no. of babies 
in the study
















Yu N et al 3/7 1 positive 36 hours 1 negative within 2 
weeks
1 negative Within 2 
weeks
Zeng L et al 33/33 3 positive Day 2 & 4 3 negative 2 on Day 
6 & 1 on 
day 7
Wang S et al 1/1 1 positive 36 hours 1 negative Day 15
Ferrazzi E etal 42/42 2 positive
1 doubtful
Day 1 2 positive
1 positive
Day 3
Alzamora MC et al 1/1 1 positive 16 hrs 1 positive 48 hrs
Khan S et al 17/17 2 positive 24 hrs Not tested
Nie R et al 26/28 1 positive 36 hrs 1 negative Day 4 1 negative Day 8 & 15
Carosso A et al 1/1 1 positive 0 hr 1 negative 37 hrs 
Hu X et al 7/7 1 positive 36 hr Not tested
Diaz SA et al 1/1 1 negative Day 6 1 positive Day 8 1 positive Day 13
Zamaniyan M et al 1/1 1 negative 0 hr 1 positive 24 hrs 1 positive 1 week
Hantoushzadeh S 
et al
5/9 5 negative Day 1 1 positive Day 7 
Kirtsman M et al 1/1 1 positive At birth 1 positive Day 2 1 positive Day 3
This table includes all babies who were positive on RT-PCR at some point. Out of the 18 babies who were positive at some point, 
only 3 have positive result after 5 days of life. These 3 babies had initial negative result. All the rest had positive result within first 
5 days and either became negative or were not tested further or continued to have positive result but these were within first 5 days.
Table I.  – RT-PCR results in babies tested positive.
increased risk of admission to an intensive care 
unit (ICU) (Allotey et al., 2020). There was an 
increased likelihood of admission to the ICU (odds 
ratio (OR) 1.62, 95% CI 1.33 - 1.96) and requiring 
invasive ventilation (OR 1.88, 95% CI 1.36 -2.60) 
among pregnant women compared to non-pregnant 
women with COVID-19. Confirmed SARS-CoV-2 
positive patients had a higher risk of delivering 
preterm and infants born to these mothers were 
more likely to be admitted to the neonatal intensive 
care unit. A quarter of all neonates from positive 
mothers were admitted to ICU. There appeared to 
be a 7% positivity rate among women universally 
screened for COVID-19 during pregnancy (Allotey 
et al., 2020). The rates of spontaneous and overall 
preterm birth were 6% and 17% respectively, while 
of the 11,000 pregnant women with SARS-CoV-2, 
73 died (Allotey et al., 2020). Of 598 hospitalised 
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SARS-CoV-2 vertical transmission (Woloshin et 
al., 2020). Our data and interpretation suggest the 
need to improve our understanding when testing 
has to be performed and when to repeat to reach a 
meaningful clinical decision process and especially 
where validation of test had not occurred, the 
sensitivity not reported and where gold standard 
and controls remained obscure. What is now 
known is that there can be 100% false negatives on 
the first day of showing symptoms from an infected 
individual and dropping to 67% on day 4. Thus, the 
validity of the RT-PCR post symptoms would only 
be valid from days 5 to 12 after which RT-PCR 
becomes negative (Kucirka et al., 2020). In four 
cohorts, 100% of patients initially tested negative 
Table II.  – Maternal characteristics.
Study Age Parity Gestation Contact 
history
Co-morbidities Outcome
Yu N et al 38 G3P2 39+6 No Hypothyroidism recovered
Zeng L et al 40 NRx NR recovered
40+4 NR NR recovered
31+2 NR NR recovered
Wang S et al 34 40 Yes Hypothyroidism recovered
Ferrazzi E etal Mean-34.6 NR NR recovered
Alzamora MC et al 41 G3P2 33 Yes Prev 2 CS
Diabetes
recovered
Khan S et al 29(24-34) 38(35+5 -41) Yes NR recovered
Nie R et al NR NR recovered
Carosso A et al 28 G2P1 37 NR GDM recovered
Hu X et al 34 40 Yes None recovered




Zamaniyan M et al 32+2 Yes hypothyroidism Died









Hypothyroidism and advanced maternal age were a common maternal morbidity. Elderly mums. For babies with positive results 
after D5 – 2 mums were critically ill and died after delivery. xNR- Not recorded.
pregnant women with SARS-Cov-2, about 55% 
were asymptomatic (Delahoy et al., 2020). 
Vertical transmission and congenital abnormalities 
experienced with Zika virus raise concerns about 
SARS-Cov-V-2 (Krauer et al., 2017; Hintley et al., 
2020).
If more than half of SARS-CoV-2 infected 
pregnant women were asymptomatic there are 
healthcare implications in managing all patients 
and staff within a clinical setting (Delahoy et 
al., 2020). Equally the meaningfulness of the 
SARS-CoV-2 diagnostic analyses needs to be 
addressed against the backdrop of high levels 
of false negatives results relying on a single test 
which would thereby not inform us a true value of 





Transaminitis Others RT-PCR (all positive)






Zeng L et al Fever, pneumonia Nasopharyngeal
Cough, pneumonia Nasopharyngeal
Pneumonia Nasopharyngeal
Wang S et al Fever, Pneumonia yes ↑ CRP
Neutrophilia
Pharyngeal












Khan S et al Fever, SOB, cough yes yes Pharyngeal
Nie R et al Fever Throat




rectal and stool 
swab postdelivery 
positive, vaginal swab 
postdelivery negative
Hu X et al Fever yes Yes Throat














Fever, cough yes ↑ CRP
CT-pneumonia
Nasopharyngeal
Kirtsman M et al myalgia, decreased 
appetite, fatigue, 
dry cough, fever
yes Raised aPTT Nasopharyngeal
*CRP- C-reactive protein; **CT-Computed tomography; ***SOB- Shortness of breath
Table III.  – Maternal symptoms and investigation.
but turned positive after 2nd and 3rd re-tests for 
SARS-CoV-2 RNA (Kelly et al., 2020). 
False-negative testing for SARS-CoV-2 is a 
serious clinically relevant problem and this should 
be overcome by serial testing in the 5-7 days 
incubation period post-infection (Kelly et al., 2020). 
In our study cohort there is no evidence that any 
of the researchers have been aware of the relevance 
of timing of testing or the need for serial testing to 
ensure the repeatability of an initial negative result 
thereby leading to inappropriate reassurances and 
conclusions about the health and status of SARS-
CoV-2 infected mothers and babies with all its 
implications for healthcare workers in attendance.
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Study No. of positive 
babies





Yu N et al 1 39+6 CS 8-9,9-10 3250
Zeng L et al 1 40 CS NR 3250
1 40+4 CS NR 3360
1 31+2 CS 3,4,5 1580
Wang S et al 1 40 CS 8,9 3205
Ferrazzi E etal 2 SVD >7 at 5 min 3224
SVD NR (Good condition) NR
Alzamora MC et al 1 33 CS 6,8 2970
Khan S et al 2 38(35+5 -41) CS 9,10 3104 (mean)
Nie R et al 1 CS 8-10,9-10 NR




Hu X et al 1 40 CS 8,9 3250
Diaz SA et al 1 38+4 CS 7,9 2500
Zamaniyan M et al 1 32+2 CS 8,9 2350
Hantoushzadeh S 
et al
1 30+5 CS 9,10 2100
Kirtsman M et al 1 35+5 CS 9,9 2930
 *Caesarean section; **SVD-Spontaneous vaginal delivery; ***NR- Not recorded
Table IV.  – Baby characteristics.
The most striking feature from our data analyses 
of 84 studies was the over-reliance on a single RT-
PCR negative test in 41 papers and the absence of 
documentation of time that the sample were taken in 
28 papers (Figure 1). Given the incubation period, 
a single result cannot be used meaningfully, and 
conclusions remain unsupported by the available 
evidence. In 82.5% babies, only 1 negative RT-
PCR done on an average on day 1 was relied 
upon. Even in babies having had 2nd negative 
RT-PCR, the test was done within 96 hours/ day 4. 
Based upon the understanding that the incubation 
period is > 5 days, the validity of this testing is 
questionable. In the few sequential tests performed 
these appeared more random rather than scientific 
reasoning in relation to the incubation period for 
SARS-CoV-2 viral infection.
Antibody testing has very limited value in 
unravelling the status of vertical transmission. 
IgG molecules can travel across the placental 
membranes; hence its’ presence does not support 
or refute vertical transmission. In two studies 
involving babies having positive IgM, there was no 
other supporting information supporting vertical 
transmission. In addition, RT-PCR in these babies 
was negative. From our analyses there remains 
sparse and meaningless information of the time for 
the production of IgM and IgG along with limited 
publication and possibly antibodies are more 
significant for long term immunity.
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Yu N et al mild SOB not ventilated 14 NR















Ferrazzi E etal NR NR NR No Yes
GI symptoms. Had resp symptoms 
after 3 days
Ventilated 24 hrs 1 Yes No
Alzamora MC 
et al
mild resp difficulty, sporadic 
cough
Ventilated NR yes No
Khan S et al Neonatal pneumonia NR NR NR
Nie R et al Pulmonary infection No treatment 
required
16 Yes
Carosso A et al Asymptomatic Not ventilated NR Yes
Hu X et al Aymptomatic NR NR Yes
Diaz SA et al Respiratory distress CPAP x2hours 5 Yes           (isolated 
















1 Yes Yes 
*NR- Not recorded ; ** CPAP- Continuous Positive Airway Pressure; ***CT- Computed tomography
Table V.  – Baby symptoms & treatment details.
The strength of our study was the analysis of a 
substantial data set of publications and the manner 
in which the diagnostic tests were performed, 
revealing poor interpretation and meaningful follow 
up. Given the diagnostic tests were developed on 
the SARS Middle Eastern strain and in the period 
of study, the validation of these tests had not been 
established or undertaken and this adds to the 
weaknesses over which we do not have control. 
Little information existed in the validation of 
diagnostic tests being utilised. Numerous tests 
have come onto the market since these studies 
were reported with differing sensitivities and 
specificities (Corman et al., 2020; Bahadur et al., 
2020; Laureano and Riboldi, 2020) and its use to 
derive reassurances on major healthcare implication 
for mothers, babies and healthcare workers need 
caution. Single occasion screening is likely to miss 
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Study Placenta Amniotic fluid Cord blood Vagina Breast milk
Yu N et al Negative Negative
Zeng L et al Negative Negative Negative
Negative Negative Negative
Negative Negative Negative
Wang S et al Negative Negative Negative
Ferrazzi E etal
Alzamora MC et al
Khan S et al
Nie R et al Negative negative
Carosso A et al fetal and maternal 
side negative
negative
Hu X et al Negative
Diaz SA et al




Kirtsman M et al Positive Not tested Positive Positive
Table VI.  – Placenta, amniotic fluid, cord blood, breast milk, vaginal swab results.
potentially infected people (Viswanathan et al., 
2020) and clinicians should not rely on unexpected 
negative results and performing serial tests could 
overcome an individual test’s limited sensitivity. 
Recent studies though not covered in our analyses 
are unlikely to alter the findings of this study 
as concerns about the lack of serial diagnostic 
analyses remain. As far as we can ascertain this 
risk is minimal in our cohort analyses and our study 
remains robust and contributes to the growing body 
of information on maternal-fetal effect during the 
SARS-CoV-2 pandemic.
Vertical transmission from mother to baby is 
rare and when this occurs there are serious health 
implications for the baby. The SARS-CoV-2 
studies included in our cohort do cover placental 
pathology reports (Hosier et al., 2020, Kirstman et 
al., 2020, Schoenmakers et al., 2020, Shanes et al., 
2020). The histological analyses in these reports 
point to a strong indication that intrapartum vertical 
transmission from mother to fetus had occurred 
(Table VIII). Our data also highlight the need to 
look at vertical transmission alongside placental 
pathologies where SARS-CoV-2 invasion of the 
placenta shows the potential for severe morbidity 
in pregnant women (Hosier et al., 2020). Another 
likely case of vertical transmission indicates 
neonates should have SARS-CoV-2 testing of the 
nasopharynx, placenta and cord blood as soon 
as possible after birth, while sample timing and 
collection methods should be documented (Kirtsman 
et al., 2020). There is limited information on how 
long the women were positive for SARS Cov2 virus 
and how soon transplacental transmission occurs. 
Assuming babies acquired infection in utero nearer 
delivery, it would be expected that the babies would 












Yu N et al 1 pos 36 hours 1 neg Within 2 
week
CS, and baby 
was isolated for 
14 days
Placenta and cord blood neg.
Contamination- baby showed mild 
SOB 
Don’t know exactly when baby 
became negative
Zeng L et al 1pos Day 2&4 1 neg Day 6 Cs, isolation Cord blood and amniotic fluid neg.
Positive in <5 days
1pos Day 2&4 1 neg Day 6 CS isolation Cord blood and amniotic fluid neg.
Positive in <5 days









Wang S et al 1 pos 36 hrs 1 neg Day 15 Long gap be-
tween 1st and 2nd 
RT-PCR- dif-
ficult to know 
if baby was 
positive within a 
week (5-7 days)
Placenta and cord blood neg
Baby asymptomatic
Ferrazzi E et al 2 pos Day 1 2 pos Day 3 Vaginal fluid contamination
Likely contamination. RT-PCR not 
repeated after 5 days.
Babies were relatively asymptomatic.
1 doubtful Few hours 
after birth
1 pos Day 3 -do-
Alzamora MC et al 1 pos 16 hrs 1 pos 48 hrs CS Baby positive <5 days. 
Had resp difficulty and needed 
ventilated but was premature at 33 
weeks? Cause is prematurity.
Khan S et al 2 pos 24 hrs Not tested CS
neonatal 
pneumonia
Insufficient information- pos at 24 
hours and not repeated. 
Nie R et al 1 pos 36 hrs 1 neg Day 4 Neg at D4
Placenta cord blood neg
Isolated for 16 days
?contamination
Carosso A et al 1 pos 0 hr 1 neg 37 hrs 
(on same 
swab)
Vaginal contamination highly 
likely as same swab neg after 37 
hours. Possibly low titres…





Diaz SA et al 1 neg Day 67 1 pos Day 8 High likelihood of ex-utero infec-
tion from Mum- Mum BF till D6 
when baby showed symptoms and 
was tested.
Zamaniyan M et al 1 neg 0 hr 1 pos 24 hrs Amniotic fluid positive. If it was 
amniotic fluid contamination- 
should have been positive at birth 
as well. Cord blood was negative 
so unlikely vertical transmission? 
infection exutero?
Table VII.  – Evidence for and against vertical transmission - Inconsistencies in the timing and repetition of RT-PCR makes it difficult 
to come to an inference — 1/2.
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viral load was much higher in placental tissue than 
in amniotic fluid and maternal or neonatal blood 
(Vivanti et al., 2020) (Table VIII). Recent studies 
suggest SARS-CoV-2 vertical transmission, the 
associated chronic placental insufficiency, as well 
as miscarriage and fetal growth restriction (Gengler 
et al., 2020), while a systematic analysis shows a 
3.3% intrapartum vertical transmission (Raschetti 
et al., 2020). Strong evidence of transplacental 
transmission in early pregnancy associated with 
hydrops fetalis and fetal demise due to SARS-CoV-2 
is also reported (Shende et al., 2020).
It seems that the timing of diagnostic tests and 
interpretation of results are not standardised in an 
obstetric medicine setting. From our data, it appears 
there is inconsistency in the tests, timing and 
repeatability of RT-PCR, adding to the uncertainty 
to reach credible inferences leading to likely false 
and inconsistent healthcare reassurances in relation 
to SARS-CoV-2 infectivity. Importantly, the 
incubation period and the timing of testing which 
could account for false-negative results appear to 
have been overlooked or not factored-in most studies 
in our cohort. Where repeat testing was performed 
this was not based on any critical scientific rationale. 
Despite a large volume of publications being added 
every month, there remains a fundamental absence 
of serial testing and over-reliance on a single test that 
underestimates the true positive cases as highlighted 
with our study. 
The most important question in reproductive and 
fetal medicine to be answered is whether there is a 
vertical transmission of SARS-CoV-2 virus from 
mother to baby and if there is an increased incidence 
of congenital malformations. This paper reveals 












Yu N et al 1 pos 36 hours 1 neg Within 2 
week
CS, and baby 
was isolated for 
14 days
Placenta and cord blood neg.
Contamination- baby showed mild 
SOB 
Don’t know exactly when baby 
became negative
Zeng L et al 1pos Day 2&4 1 neg Day 6 Cs, isolation Cord blood and amniotic fluid neg.
Positive in <5 days
1pos Day 2&4 1 neg Day 6 CS isolation Cord blood and amniotic fluid neg.
Positive in <5 days









*CS-Caesarean section; **PPROM-Prelabour premature rupture of membranes
Table VII.  – Evidence for and against vertical transmission - Inconsistencies in the timing and repetition of RT-PCR makes it difficult 
to come to an inference — 2/2.
be positive after the incubation period, most likely 
in the five days following delivery. In our review, 
there were only two babies who were negative soon 
after delivery but became positive five days later and 
one who became positive at 24 hours and continued 
to be positive at one week. All the other babies had 
positive RT-PCR within five days of birth.  Of these 
three babies, two had positive amniotic fluid raising 
the possibility of vertical transmission (Table VI). 
Had it been contamination from amniotic fluid, RT-
PCR would be expected to be positive in the initial 
testing soon after birth (Table VII). 
Given that the majority of pregnant women 
appear asymptomatic or have nonspecific 
symptoms (Table III), it was remarkable to have 
confirmation of SARS-CoV-2 placental damage, 
detection of SARS-CoV-2 RNA and the presence 
of whole viral particles on both maternal and 
fetal aspects of the placenta (Schoenmakers et al., 
2020). Placental histological changes (Kirtsman et 
al., 2020; Shanes et al., 2020) provide important 
supporting tools to SARS-CoV-2 diagnostic testing 
when deciphering vertical transmission, especially 
considering that the majority of pregnant women 
appear asymptomatic although other infection routes 
such as through being born vaginally, breastfed or 
remaining with the infected mother (Walker et al., 
2020). Several infected babies within 12 hours 
suggest an incubation period pre-existed the delivery 
to suggest vertical transmission (Table V). PCR 
positive SARS-CoV-2 tests in the amniotic fluid 
and infant provide important support for vertical 
transmission in SARS-CoV-2 infected pregnant 
women (Zamaniyan et al., 2020). A recent report 
outside our study cohort provides compelling data 
on vertical transmission and where the RT-PCR 
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Table VIII.  – Placental histology.
Study No. of 
women
No. of babies Placental histology
Schoenmakers S et al 1 1 negative Placenta showed the presence of SARS-CoV-2 particles with 
generalized inflammation characterized by histiocytic intervillositis 
with diffuse perivillous fibrin depositions with damage to the 
syncytiotrophoblasts.The maternal side of the placenta had a viral 
load of 4.42 log copies /mL, while the fetal side had 7.15 log 
copies /mL.
Hosier H et al 1 MTOP-negative The placenta was remarkable for the presence of diffuse perivillous 
fibrin and an inflammatory infiltrate composed of macrophages as 
well as T lymphocytes, consistent with histiocytic intervillositis. 
SARS–CoV-2 localized predominantly to the syncytiotrophoblast 
cells of the placenta.
Shanes ED 16 15 babies negative
1 miscarriage- not 
tested
Placentas show increased prevalence of decidual arteriopathy 
and other features of maternal vascular malperfusion, a pattern of 
placental injury reflecting abnormalities in oxygenation within the 
intervillous space associated with adverse perinatal outcomes. 
Kirtsman M et al 1 1 positive Placenta showed multiple areas of infiltration by inflammatory cells 
and extensive early infarction, largely confined to the intervillous 
space, consistent with chronic histiocytic intervillositis. There was 
extensive early necrosis of the syncytiotrophoblast layer.
*MTOP- Medical termination of pregnancy
diagnostic analyses is not accurately detected and 
it disregards the viral incubation period, placental 
pathologies and peripheral supporting data, thereby 
under-reporting mother to baby vertical transmission. 
In conclusion, the vast body of information 
generated during this SARS-CoV-2 pandemic may 
falsely reassure the public about the overall level 
of mother to baby viral transmission since serial 
testing after a negative test was not performed 
in over 80% of newborns. It is more important 
to amalgamate the diagnostic testing with good 
microscopic and histological analyses of the 
placenta for vertical transmission of SARS-CoV-2 
to be assessed. The collective information of 
diagnostic analysis, incubation periods, placental 
and amniotic fluid data and increasingly positive 
cases suggest the argument for intrapartum vertical 
transmission is compelling and transmission from 
mother to baby cannot be dismissed.
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COVID-related papers  and webinars are receiving 
special attention with the covid repository at the 
Centers for Disease Control and Prevention (CDC) 
Atlanta.
Hopkins Center for Humanitarian Health, Johns 




MedPage is also especially reporting pregnancy 
covid related papers: https://www.medpagetoday.
com/infectiousdisease/covid19 
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Study Year Title Link
Yu N et al 2020 Clinical features and obstetric and neonatal 
outcomes of pregnant patients with COVID-19 





Zeng L et al 2020 Neonatal Early-Onset Infection With SARS-CoV-2 









Ferrazzi E etal 2020 Mode of Delivery and Clinical Findings in 









Khan S et al 2020 Association of COVID-19 infection with pregnancy 
outcomes in healthcare workers and general women.
https://www.ncbi.nlm.nih.gov/pmc/ar-
ticles/PMC7141623/pdf/main.pdf
Nie R et al 2020 Clinical features and the maternal and neonatal out-




Carosso A et al 2020 Pre-labor anorectal swab for SARS-CoV-2 in 




Hu X et al  2020 Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2) Vertical Transmission in Neonates 








Diaz SA et al 2020 Neonatal first case of SARS-CoV-2 in SpainFirst 





Zamaniyan M et al  2020 Preterm delivery in pregnant woman with critical 









2020 SARS-CoV-2 placental infection and inflammation 
leading to fetal distress and neonatal multi-organ 
failure in an asymptomatic woman.
https://doi.
org/10.1101/2020.06.08.20110437
Hosier H et al  2020 SARS–CoV-2 infection of the placenta https://doi.org/10.1172/JCI139569
Shanes ED 2020 Placental pathology in COVID. https://doi.org/10.1093/ajcp/aqaa089
Kirtsman M et al  2020 Probable congenital SARS-CoV-2 infection in a 
neonate born to a woman with active SARS-CoV-2 
infection.
doi: 10.1503/cmaj.200821
Table IX.  – List of studies with babies positive for COVID 19.
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